Redox‐Responsive AIEgen Diselenide‐Covalent Organic Framework Composites Targeting Hepatic Macrophages for Treatment of Drug‐induced Liver Injury

Abstract The escalating misuse of antipyretic and analgesic drugs, alongside the rising incidents of acute drug‐induced liver injury, underscores the need for a precisely targeted drug delivery system. Herein, two isoreticular covalent organic frameworks (Se‐COF and Se‐BCOF) are developed by Schiff‐base condensation of emissive tetraphenylethylene and diselenide‐bridged monomers. Leveraging the specific affinity of macrophages for mannose, the first precise targeting of these COFs to liver macrophages is achieved. The correlation is also explored between the therapeutic effects of COFs and the NLRP3/ASC/Caspase‐1 signaling pathway. Utilizing this innovative delivery vehicle, the synergistic delivery of matrine and berberine are accomplished, compounds extracted from traditional Chinese medicine. This approach not only demonstrated the synergistic effects of the drugs but also mitigated their toxicity. Notably, berberine, through phosphorylation of JNK and up‐regulation of nuclear Nrf‐2 and its downstream gene Mn‐SOD expression, simultaneously countered excessive ROS and suppressed the activation of the NLRP3/ASC/Caspase‐1 signaling pathway in injured liver tissues. This multifaceted approach proved highly effective in safeguarding against acute drug‐induced liver injury, ultimately restoring liver health to normalcy. These findings present a novel and promising strategy for the treatment of acute drug‐induced liver injury.